•  
  •  
  •  
  •  

2025-08-31 20:12:24

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Titan unveils 8 new brand outlets across Delhi NCR, strengthening their retail footprint with 1000+ stores in FY26
  • Zigly Unveils New Experience Centre at Phoenix Marketcity, Strengthens Mumbai Presence
  • XTGlobal Infotech Ltd and ICICI Bank Ltd enter into loan agreement
  • NCC Limited receives orders worth Rs. 788.34 crore
  • Thomas Cook India & SOTC Travel ink long-term strategic MOU with Queensland Tourism

Keywords Selected:  Pharmaceuticals

Research

  • Kotak Institutional Equities - Pharmaceuticals: IPM pulse - gaining momentum
  • Company Update - P&G Health - ICICI Direct
  • Quant Pick - Cadila Healthcare - ICICI Direct
  • Q2FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Lack of near term triggers - YES Securities
  • Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities

IPO News

  • Accretion Pharmaceuticals' IPO Opens for subscription today, Price Band set at ₹96-101 per Share
  • Accretion Pharmaceuticals Ltd IPO to open for subscription on May 14, 2025
  • Senores Pharmaceuticals IPO subscribed 13.93 times on Day 2
  • Senores Pharmaceuticals IPO fully subscribed on Day 1
  • Senores Pharmaceuticals gets Sebi nod for IPO

Stock Report

  • Apitoria Pharma Pvt Ltd receives 5 observations from USFDA for API facility
  • Shukra Pharmaceuticals Ltd awarded contract by HSCC India Ltd
  • Sai Life Sciences completes Phase II of Production Block 11 at Bidar, India, expands capacity to 700 KL
  • Koanna International FZ LLC and PPI Launch Joint Venture to Build New Pharma Manufacturing Facility in Saudi Arabia
  • SMS Pharmaceuticals Ltd receives EIR from USFDA for Central Laboratory Analytical Services
  • Unichem Laboratories Ltd receives EIR from USFDA classifying Roha API facility as VAI
  • Eris Lifesciences receives ANVISA approval for Sterile Injectable Facility
  • CuraTeQ Biologics receives approval for biosimilar Dazublys from UK's MHRA
  • Remedium Lifecare charts 4X Growth Path with Strategic Focus on 4-Point Strategy
  • Shelter Pharma Ltd receives new order
  • GSK forays into Oncology in India with Jemperli and Zejula, Bringing Precision Therapies for Gynaecological Cancers
  • Eris Lifesciences Receives ANVISA approval at its Ahmedabad campus
  • Crisil ESG Ratings & Analytics Ltd assigns Crisil ESG 57 rating to Mankind Pharma Limited
  • Akums Drugs and Pharmaceuticals Ltd signs framework agreement with Government of Zambia
  • Mangalam Drugs and Organics Ltd receives repeat export order worth $ 21,81,040
  • Veerhealth Care received further repeat Export Order from existing USA customer
  • Piramal Pharma Solutions and NewAmsterdam Pharma announce dedicated OSD production Capabilities at Piramal's Sellersville, Pennsylvania Site
  • Concord Biotech Limited completes EUGMP inspection at its API facility
  • Lupin launches Bosentan Tablets for Oral Suspension in the United States with 180-Day Exclusivity
  • Jeena Sikho Lifecare Ltd receives NABH certification
  • Alkem launches Olesoft Trucera, an advanced ceramide-boosting moisturizing lotion for skin barrier repair
  • Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10mg
  • Glenmark Pharmaceuticals Inc., USA to launch Micafungin for Injection USP, 50 mg/vial and 100 mg/vial
  • Kwality Pharma receives product registration of Bleomycin 15 IU per vial in Mexico

Industry News

  • NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India

Latest Post

  • Titan unveils 8 new brand outlets across Delhi NCR, strengthening their retail footprint with 1000+ stores in FY26
  • Zigly Unveils New Experience Centre at Phoenix Marketcity, Strengthens Mumbai Presence
  • XTGlobal Infotech Ltd and ICICI Bank Ltd enter into loan agreement
  • NCC Limited receives orders worth Rs. 788.34 crore
  • Thomas Cook India & SOTC Travel ink long-term strategic MOU with Queensland Tourism


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024